Summary:
Summary Statement of Deficiencies D2016 SUCCESSFUL PARTICIPATION CFR(s): 493.803(a)(b)(c) (a) Each laboratory performing nonwaived testing must successfully participate in a proficiency testing program approved by CMS, if applicable, as described in subpart I of this part for each specialty, subspecialty, and analyte or test in which the laboratory is certified under CLIA. (b) Except as specified in paragraph (c) of this section, if a laboratory fails to participate successfully in proficiency testing for a given specialty, subspecialty, analyte or test, as defined in this section, or fails to take remedial action when an individual fails gynecologic cytology, CMS imposes sanctions, as specified in subpart R of this part. (c) If a laboratory fails to perform successfully in a CMS- approved proficiency testing program, for the initial unsuccessful performance, CMS may direct the laboratory to undertake training of its personnel or to obtain technical assistance, or both, rather than imposing alternative or principle sanctions except when one or more of the following conditions exists: (1) There is immediate jeopardy to patient health and safety. (2) The laboratory fails to provide CMS or a CMS agent with satisfactory evidence that it has taken steps to correct the problem identified by the unsuccessful proficiency testing performance. (3) The laboratory has a poor compliance history. This CONDITION is not met as evidenced by: The laboratory failed to successfully participate in White Blood Cell Differential proficiency testing by failing to achieve satisfactory performance in 2 of 3 consecutive testing events in 2018. (See D2130) D2130 HEMATOLOGY CFR(s): 493.851(f) Failure to achieve satisfactory performance for the same analyte in two consecutive events or two out of three consecutive testing events is unsuccessful performance. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- This STANDARD is not met as evidenced by: Based on Federal Casper Reports 153 and 155 review, and interview with staff, the laboratory failed to achieve successful proficiency testing (PT) performance for White Blood Cell Differential (WBCD) by failing to achieve a satisfactory score of at least 80% in 2 of 3 consecutive PT testing events (events 1 and 3 of 2018). Findings include: 1. Casper Reports 153 and 155 document scores of 67% for the 1st and 3rd events of 2018 for WBCD. 2. Staff confirmed in a telephone interview on 01/23/2019 at 4:00 p.m. the laboratory failed to achieve a satisfactory score of at least 80% in PT events 1 and 3 of 2018 for WBCD. -- 2 of 2 --